News – Page 938 – Endpoints News

Going for it: GSK’s Hal Barron outlines a big PhIII program for rheumatoid arthritis — going head-to-head with ...

6 years ago

Boston Biomedical's lead drug fizzles in difficult-to-treat pancreatic cancer

6 years ago

Just how much would no-deal Brexit harm biomedical science? Researchers speak out

6 years ago

Roche’s new flu drug continues to rack up PhIII successes — but can it beat generic Tamiflu with outcomes like ...

6 years ago

Five US states agree to suspend litigation against bankrupt opioid maker Insys — report

6 years ago

Unum shares ricochet lower as premier drug slams into its second safety crisis, FDA slaps another hold on PhI

6 years ago

Gottlieb rebuts Science report on plummeting FDA inspections; Libtayo wins EMA and NICE endorsement

6 years ago

Incyte flips China rights of MacroGenics' PD-1 to an ambitious Zai Lab keen on leapfrogging pioneers with combos

6 years ago

Ex-FDA commish Scott Gottlieb says he's 'very proud' of Pfizer post as top Dem attacks influence peddling

6 years ago

Emboldened by ASCO data, FDA etches speedy approval path for Iovance's cervical cancer therapy

6 years ago

Biogen arms itself with impressive durability stats on Spinraza as Novartis’ rival gene therapy takes the field

6 years ago

Boehringer builds out NASH pipeline with up to $870M deal with South Korea's Yuhan

6 years ago

SV joins CRUK on a $250M-plus fund with an eye on developing new cancer drugs

6 years ago

Watch out AbbVie: Gilead is fast on your heels at the FDA with rival JAK inhibitor filgotinib

6 years ago

Bullish Amarin doubling sales force in fast run-up to the big FDA decision on Vascepa

6 years ago

Merrimack CEO, CFO bow out, months after last clinical drug fizzles

6 years ago

Investors trapped for another 28 days as suspension of Woodford flagship fund drags on

6 years ago

Bayer, Versant back a $250M cell therapy startup on a quest to create off-the-shelf immuno-oncology therapies

6 years ago

Neil Woodford refreshes portfolio with fire sale while investors ponder future of suspended fund

6 years ago

Updated: Lonza sets sights on expansion, buying Novartis facility; IQVIA leads $14 million Series B funding round

6 years ago

Pfizer’s gamble on a new lease on life for aging sildenafil franchise fizzles in PhIII

6 years ago

In another shakeup, uBiome brings in outside help to revamp a microbiome testing operation under FBI scrutiny

6 years ago

Tesaro vet jumps to an Irish oncology upstart and shifts focus to the US, eyeing fundraising

6 years ago

Analysts see promise in FibroGen's early Duchenne study — now they want to see a pivotal trial

6 years ago

First page Previous page 935 936 937938939 940 941 Next page Last page